Suchergebnisse - "Hydroxychloroquine"

PubPharm (379)

1

Correspondence on 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine'

enthalten in: Annals of the rheumatic diseases | 2023

von Martelli Júnior, H. | Marques, N. | Marques, N. | +3

CommentOn: Ann Rheum Dis. 2020 Jun;79(6):837-839. - PMID 32332072

2

Correspondence on 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine'

enthalten in: Annals of the rheumatic diseases | 2023

von Gupta, S. | Nakabo, S. | Chu, J. | +2

3

Why the article that led to the widespread use of hydroxychloroquine in COVID-19 should be retracted

enthalten in: Therapie | 2023

von Barraud, D. | Besançon, L. | Bik, E. | +10

4

Comment on 'Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19' by Konig et al. Long-term exposure to hydroxychloroquine or chloroquine and the risk of hospitalisation with COVID-19 : a nationwide, observational cohort study in 54 873 exposed individuals and 155 689 matched unexposed individuals in France

enthalten in: Annals of the rheumatic diseases | 2023

von Sbidian, E. | Penso, L. | Herlemont, P. | +7

CommentOn: Ann Rheum Dis. 2020 Oct;79(10):1386-1388. - PMID 32381561

5

Authors' reply to : 'Generalized pustular figurate erythema first report in two COVID-19 patients on hydroxychloroquine'

enthalten in: Journal of the European Academy of Dermatology and Venereology : JEADV | 2023

von Bertello, M. | Rubegni, G. | Rubegni, P. | +1

CommentOn: J Eur Acad Dermatol Venereol. 2021 Jan;35(1):e5-e7. - PMID 32870539

6

Antirheumatic drugs, B cell depletion and critical COVID-19 : correspondence on 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine' by Mathian et al

enthalten in: Annals of the rheumatic diseases | 2022

von Notz, Q. | Meybohm, P. | Kranke, P. | +3

CommentOn: Ann Rheum Dis. 2020 Jun;79(6):837-839. - PMID 32332072

7

Experiences of the Data Monitoring Committee for the RECOVERY trial, a large-scale adaptive platform randomised trial of treatments for patients hospitalised with COVID-19

enthalten in: Trials | 2022

von Sandercock, P. | Darbyshire, J. | DeMets, D. | +7

8

COVID-19 drug research and the cohort multiple randomised controlled trial design

enthalten in: The European respiratory journal | 2022

von Dal-Ré, R.

CommentOn: Eur Respir J. 2022 Aug 10;60(2):. - PMID 35115337

9

Reply : COVID-19 drug research and the cohort multiple randomised controlled trial design

enthalten in: The European respiratory journal | 2022

von Porcher, R. | Ravaud, P. | Resche-Rigon, M. | +3

CommentOn: Eur Respir J. 2022 Aug 10;60(2):. - PMID 35115337

10

An open-label randomized, controlled trial of the effect of lopinavir and ritonavir, lopinavir and ritonavir plus interferon-β-1a, and hydroxychloroquine in hospitalized patients with COVID-19 : final results

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2022

von Ader, F. | DisCoVeRy Study Group

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[38]